Publication Name	World Journal of Gastroenterology
Manuscript ID	56239
Country	United States

Received	2020-04-22 21:41
Peer-Review Started	2020-04-22 21:42
To Make the First Decision
Return for Revision	2020-05-15 22:55
Revised	2020-08-14 22:28
Second Decision	2020-08-31 11:28
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2020-08-31 20:04
Articles in Press	2020-08-31 20:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-09-14 12:25
Publish the Manuscript Online	2020-09-28 07:42

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Opinion Review
Article Title	Review of inflammatory bowel disease and COVID-19
Manuscript Source	Unsolicited Manuscript
All Author List	Keith Sultan, Anjali Mone, Laura Durbin, Samreen Khuwaja and Arun Swaminath
Funding Agency and Grant Number
Corresponding Author	Keith Sultan, MD, Associate Professor, Division of Gastroenterology, Northwell Health, North Shore University Hospital and Long Island Jewish Medical Center, 600 Northern BLVD, Suite 111, Great Neck, NY 10021, United States. ksultan@northwell.edu
Key Words	Inflammatory bowel disease; COVID-19; SARS-CoV-2; Corona virus; Pandemic;
Core Tip	The rapid spread of coronavirus disease 2019 (COVID-19) has impacted patients and medical practice across the globe. While all individuals are at risk for COVID-19, this risk is of particular concern to those with compromised immune systems. Inflammatory bowel disease (IBD) patients are presumed to be particularly vulnerable, particularly those on immune suppressing/modifying medications. There has been rapid publication of peer reviewed source material and expert opinion addressing IBD experience, outcomes, and management in the age of COVID-19. This review provides a concise summary to help facilitate safe and effective patient management.
Publish Date	2020-09-28 07:42
Citation	Sultan K, Mone A, Durbin L, Khuwaja S, Swaminath A. Review of inflammatory bowel disease and COVID-19. World J Gastroenterol 2020; 26(37): 5534-5542
URL	https://www.wjgnet.com/1007-9327/full/v26/i37/5534.htm
DOI	https://dx.doi.org/10.3748/wjg.v26.i37.5534

Full Article (PDF)	WJG-26-5534.pdf
Full Article (Word)	WJG-26-5534.docx
Manuscript File	56239-Review.docx
Answering Reviewers	56239-Answering reviewers.pdf
Audio Core Tip	56239-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	56239-Conflict-of-interest statement.pdf
Copyright License Agreement	56239-Copyright license agreement.pdf
Peer-review Report	56239-Peer-review(s).pdf
Scientific Misconduct Check	56239-Bing-Yan JP-1.png
Scientific Misconduct Check	56239-Scientific misconduct check.pdf
Scientific Editor Work List	56239-Scientific editor work list.pdf
CrossCheck Report	56239-CrossCheck Report.pdf